Paul Hastings

Insider profile

Currently holds positions in Protara Therapeutics Inc and Pacira Biosciences Inc

Performance

Overall performance
2.8

Performance over holding periods
2.8
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director Protara Therapeutics Inc Jan. 1, 2017 -
Lead Independent Director Pacira Biosciences Inc June 1, 2013 -
Chairman of the Board, Chief Executive Officer OncoMed Pharmaceuticals Inc Sept. 18, 2017 - Jan. 1, 2018
Chairman of the Board, President, Chief Executive Officer OncoMed Pharmaceuticals Inc Jan. 1, 2014 - Sept. 18, 2017
Chairman of the Board Protara Therapeutics Inc Oct. 18, 2016 - Jan. 1, 2017
President, Chief Executive Officer and Board Member OncoMed Pharmaceuticals Inc None -
Independent Director Pacira Biosciences Inc June 2, 2011 - June 1, 2013

Paul Hastings's trades of Nkarta Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
84.86
Quantity 73,215 -23.6%
Value US$3,753,716
Transaction date
Planned sale
Price
221.16
Quantity 39,873 +45.7%
Value US$1,460,778
Transaction date
Sale
Price
110.35
Quantity 35,709 -20.0%
Value US$3,806,429
Transaction date
Planned sale
Price
1.79
Quantity 1,790 -0.6%
Value US$3,204
Transaction date
Sale
Price
2.20
Quantity 17,378 -5.2%
Value US$38,232
Transaction date
Sale
Price
5.60
Quantity 1,770 -0.7%
Value US$9,912
Transaction date
Proposed sale
Price
28.38
Quantity 880
Value US$24,974
Transaction date
Proposed sale
Price
12.84
Quantity 60,000
Value US$770,400
Transaction date
Proposed sale
Price
12.08
Quantity 120,000
Value US$1,449,600
Transaction date
Sale
Price
8.74
Quantity 9,697 -2.4%
Value US$84,752
Transaction date
Planned sale
Price
4.85
Quantity 1,704 -0.5%
Value US$8,264
Transaction date
Sale
Price
38.34
Quantity 580 -8.1%
Value US$22,237
Transaction date
Proposed sale
Price
38.34
Quantity 580
Value US$22,236
Transaction date
Proposed sale
Price
41.85
Quantity 7,000
Value US$292,950
Transaction date
Planned sale
Price
5.49
Quantity 3,691 -1.2%
Value US$20,264
Transaction date
Planned sale
Price
13.01
Quantity 6,126 -2.2%
Value US$79,717
Transaction date
Planned sale
Price
26.53
Quantity 223 -0.1%
Value US$5,916
Transaction date
Planned sale
Price
27.20
Quantity 8,277 -3.6%
Value US$225,134
Transaction date
Planned sale
Price
26.89
Quantity 3,807 -1.6%
Value US$102,370
Transaction date
Planned sale
Price
26.39
Quantity 4,693 -2.0%
Value US$123,848
Transaction date
Planned sale
Price
32.21
Quantity 3,130 -1.3%
Value US$100,817
Transaction date
Planned sale
Price
31.24
Quantity 2,409 -1.0%
Value US$75,257
Transaction date
Planned sale
Price
30.23
Quantity 11,461 -4.5%
Value US$346,466
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-22 2026-06-18 PlS Planned sale
73,215 -23.6%
84.86
US$3,753,716
73,215 -23.6% 84.86 US$3,753,716
2026-06-22 2026-06-18 PlS Planned sale
39,873 +45.7%
221.16
US$1,460,778
39,873 +45.7% 221.16 US$1,460,778
2026-01-20 2026-01-15 S Sale
35,709 -20.0%
110.35
US$3,806,429
35,709 -20.0% 110.35 US$3,806,429
2025-06-20 2025-06-18 PlS Planned sale
1,790 -0.6%
1.79
US$3,204
1,790 -0.6% 1.79 US$3,204
2025-01-17 2025-01-15 S Sale
17,378 -5.2%
2.20
US$38,232
17,378 -5.2% 2.20 US$38,232
2024-06-20 2024-06-18 S Sale
1,770 -0.7%
5.60
US$9,912
1,770 -0.7% 5.60 US$9,912
2024-06-13 2024-06-13 PrS Proposed sale
880
28.38
US$24,974
880 28.38 US$24,974
2024-06-13 2024-06-13 PlS Planned sale
880 -6.5%
28.38
US$24,974
880 -6.5% 28.38 US$24,974
2024-03-04 2024-03-04 PrS Proposed sale
60,000
12.84
US$770,400
60,000 12.84 US$770,400
2024-03-01 2024-03-01 PrS Proposed sale
120,000
12.08
US$1,449,600
120,000 12.08 US$1,449,600
2024-01-18 2024-01-16 S Sale
9,697 -2.4%
8.74
US$84,752
9,697 -2.4% 8.74 US$84,752
2023-06-22 2023-06-20 PlS Planned sale
1,704 -0.5%
4.85
US$8,264
1,704 -0.5% 4.85 US$8,264
2023-06-07 2023-06-05 S Sale
580 -8.1%
38.34
US$22,237
580 -8.1% 38.34 US$22,237
2023-06-05 2023-06-05 PrS Proposed sale
580
38.34
US$22,236
580 38.34 US$22,236
2023-05-17 2023-05-15 PlS Planned sale
7,000 -49.4%
41.85
US$292,950
7,000 -49.4% 41.85 US$292,950
2023-05-15 2023-05-15 PrS Proposed sale
7,000
41.85
US$292,950
7,000 41.85 US$292,950
2023-01-18 2023-01-17 PlS Planned sale
3,691 -1.2%
5.49
US$20,264
3,691 -1.2% 5.49 US$20,264
2022-09-22 2022-09-21 PlS Planned sale
6,126 -2.2%
13.01
US$79,717
6,126 -2.2% 13.01 US$79,717
2022-07-13 2022-07-11 PlS Planned sale
533 -6.9%
56.95
US$30,354
533 -6.9% 56.95 US$30,354
2021-10-01 2021-09-29 PlS Planned sale
223 -0.1%
26.53
US$5,916
223 -0.1% 26.53 US$5,916
2021-10-01 2021-09-29 PlS Planned sale
8,277 -3.6%
27.20
US$225,134
8,277 -3.6% 27.20 US$225,134
2021-06-23 2021-06-21 PlS Planned sale
3,807 -1.6%
26.89
US$102,370
3,807 -1.6% 26.89 US$102,370
2021-06-23 2021-06-21 PlS Planned sale
4,693 -2.0%
26.39
US$123,848
4,693 -2.0% 26.39 US$123,848
2021-06-08 2021-06-04 PlS Planned sale
630 -10.3%
62.19
US$39,180
630 -10.3% 62.19 US$39,180
2021-04-01 2021-03-30 PlS Planned sale
3,130 -1.3%
32.21
US$100,817
3,130 -1.3% 32.21 US$100,817
2021-04-01 2021-03-30 PlS Planned sale
2,409 -1.0%
31.24
US$75,257
2,409 -1.0% 31.24 US$75,257
2021-04-01 2021-03-30 PlS Planned sale
11,461 -4.5%
30.23
US$346,466
11,461 -4.5% 30.23 US$346,466
2021-03-09 2021-03-05 S Sale
3,000 -32.9%
65.88
US$197,640
3,000 -32.9% 65.88 US$197,640
2020-06-08 2020-06-04 S Sale
2,025 -29.4%
47.46
US$96,106
2,025 -29.4% 47.46 US$96,106
2019-06-06 2019-06-04 PlS Planned sale
782 -22.2%
42.66
US$33,360
782 -22.2% 42.66 US$33,360
2017-10-12 2017-10-10 S Sale
52 -0.1%
4.26
US$222
52 -0.1% 4.26 US$222
2016-06-08 2016-06-06 PlS Planned sale
1,136 -39.8%
46.95
US$53,335
1,136 -39.8% 46.95 US$53,335
2016-01-08 2016-01-06 PlS Planned sale
2,335 -9.6%
22.30
US$52,072
2,335 -9.6% 22.30 US$52,072